Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

THERAPEUTIC COMBINATION FOR TREATMENT OF CEREBELLAR ATAXIA

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • Publication Date:
    May 9, 2019
  • معلومة اضافية
    • Document Number:
      20190134007
    • Appl. No:
      16/182965
    • Application Filed:
      November 07, 2018
    • نبذة مختصرة :
      Provided herein are combinations of therapeutic agents useful for the treatment of cerebellar ataxia and methods of use thereof. In particular, embodiments herein baclofen and chlorzoxazone are administered for the treatment of cerebellar ataxia.
    • Claim:
      1. A method of treating a subject suffering from cerebellar ataxia, comprising: administering to a subject baclofen and chlorzoxazone, such that the cerebellar ataxia or symptoms thereof are reduced or eliminated.
    • Claim:
      2. The method of claim 1, wherein the subject is human.
    • Claim:
      3. The method of claim 1, wherein the baclofen and chlorzoxazone are co-formulated in a single pharmaceutical composition.
    • Claim:
      4. The method of claim 1, wherein the baclofen and chlorzoxazone are separately-formulated in a single pharmaceutical composition.
    • Claim:
      5. The method of claim 1, wherein the baclofen and chlorzoxazone are in separate pharmaceutical compositions.
    • Claim:
      6. The method of claim 5, wherein the separate pharmaceutical compositions are co-administered sequentially.
    • Claim:
      7. The method of claim 6, wherein administrations are separated by a delay of at least 1 hour.
    • Claim:
      8. The method of claim 6, wherein administrations are separated by a delay of at least 1 day.
    • Claim:
      9. The method of claim 1, further comprising a step comprising testing the subject cerebellar ataxia.
    • Claim:
      10. The method of claim 9, further comprising the step of assessing the effectiveness of treatment based upon said testing.
    • Claim:
      11. The method of claim 10, further comprising adjusting the treatment based on said assessing.
    • Claim:
      12. The method of claim 11, wherein adjusting the treatment comprises one or more of: altering the dose of baclofen, altering the dose of chlorzoxazone, altering the dosing regimen of baclofen, altering the dosing regimen of chlorzoxazone, or adding additional treatment.
    • Claim:
      13. A pharmaceutical composition comprising baclofen and chlorzoxazone.
    • Claim:
      14. The method of claim 13, wherein the baclofen and chlorzoxazone are co-formulated in a single pharmaceutical composition.
    • Claim:
      15. The method of claim 13, wherein the baclofen and chlorzoxazone are separately-formulated in a single pharmaceutical composition.
    • Claim:
      16. A kit or system comprising a first pharmaceutical composition comprising baclofen and a second pharmaceutical composition comprising chlorzoxazone.
    • Current International Class:
      61; 61; 61
    • الرقم المعرف:
      edspap.20190134007